These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26512963)

  • 1. DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis.
    Zhou J; Ning Z; Wang B; Yun EJ; Zhang T; Pong RC; Fazli L; Gleave M; Zeng J; Fan J; Wang X; Li L; Hsieh JT; He D; Wu K
    Cell Death Dis; 2015 Oct; 6(10):e1955. PubMed ID: 26512963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of DAB2IP in androgen receptor activation during prostate cancer progression.
    Wu K; Liu J; Tseng SF; Gore C; Ning Z; Sharifi N; Fazli L; Gleave M; Kapur P; Xiao G; Sun X; Oz OK; Min W; Alexandrakis G; Yang CR; Hsieh CL; Wu HC; He D; Xie D; Hsieh JT
    Oncogene; 2014 Apr; 33(15):1954-63. PubMed ID: 23604126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DAB2IP regulates intratumoral testosterone synthesis and CRPC tumor growth by ETS1/AKR1C3 signaling.
    Gu Y; Wu S; Chong Y; Guan B; Li L; He D; Wang X; Wang B; Wu K
    Cell Signal; 2022 Jul; 95():110336. PubMed ID: 35452821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
    Yang C; He H; Zhang T; Chen Y; Kong Z
    Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
    Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
    Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway.
    Zhang D; He D; Xue Y; Wang R; Wu K; Xie H; Zeng J; Wang X; Zhau HE; Chung LW; Chang LS; Li L
    Cancer Res; 2011 Mar; 71(6):2193-202. PubMed ID: 21385902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression.
    Huang S; Liu Q; Liao Q; Wu Q; Sun B; Yang Z; Hu X; Tan M; Li L
    Cancer Sci; 2018 Mar; 109(3):678-687. PubMed ID: 29288516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
    Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells.
    Kong Z; Raghavan P; Xie D; Boike T; Burma S; Chen D; Chakraborty A; Hsieh JT; Saha D
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1210-8. PubMed ID: 20970033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.
    Xie D; Gore C; Liu J; Pong RC; Mason R; Hao G; Long M; Kabbani W; Yu L; Zhang H; Chen H; Sun X; Boothman DA; Min W; Hsieh JT
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2485-90. PubMed ID: 20080667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling.
    Wu K; Wang B; Chen Y; Zhou J; Huang J; Hui K; Zeng J; Zhu J; Zhang K; Li L; Guo P; Wang X; Hsieh JT; He D; Fan J
    Cell Signal; 2015 Dec; 27(12):2515-23. PubMed ID: 26410305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
    Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
    Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
    Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
    Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
    Jeon YJ; Jung SN; Yun J; Lee CW; Choi J; Lee YJ; Han DC; Kwon BM
    Cancer Sci; 2015 Apr; 106(4):413-20. PubMed ID: 25611086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein.
    Wang B; Huang J; Zhou J; Hui K; Xu S; Fan J; Li L; Wang X; Hsieh JT; He D; Wu K
    Cell Signal; 2016 Nov; 28(11):1623-30. PubMed ID: 27476001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
    Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
    Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
    Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
    Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.